Foster Victor Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Foster Victor Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$398K	Hold	12,500	–	–	0.02%	200
2026 Q1	$397K	Hold	12,500	–	–	0.02%	187
2025 Q4	$397K	Hold	12,500	–	–	0.02%	178
2025 Q3	$250K	Hold	12,500	–	–	0.02%	196
2025 Q2	$209K	Hold	12,500	–	–	0.01%	191
2025 Q1	$168K	Buy	+12,500	New	+$223K	0.01%	190

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Foster Victor Wealth Advisors's TEVA Position: Q2 2026 in Review

Foster Victor Wealth Advisors held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 12,500 shares worth $398K. The position accounts for 0.02% of the portfolio, ranked #200.

Foster Victor Wealth Advisors first reported a position in TEVA in Q1 2025 and has held it in 6 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Foster Victor Wealth Advisors held 12,500 shares of Teva Pharmaceuticals worth $398K as of Q2 2026.
Foster Victor Wealth Advisors left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up 0.02% of Foster Victor Wealth Advisors's portfolio in Q2 2026, its #200 holding.
Foster Victor Wealth Advisors first reported a position in Teva Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Foster Victor Wealth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.